Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

LaunchCyte

1.Contact LaunchCyte   (100%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT CONTACT US LaunchCyte, LLC 100 Technology Drive Suite 440 Pittsburgh, PA 15219 info@launchcyte.com Phone: (412) 770-1630 Fax: (412) 770-1638 Tom Petzinger, Partner/CEO tom@launchcyte.com copyright © 2004, 2205 LaunchCyte LLC. ALL RIGHTS R...
2.About LaunchCyte   (98%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT ABOUT US LaunchCyte sources technologies through a rich network of university partners and other contacts. We evaluate them with a science staff trained in business, emphasizing high-risk, early-stage technology concepts. We finance and help d...
3.Welcome to LaunchCyte   (91%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT WELCOME TO THE HOME OF BIOTECH VENTURE CREATION LaunchCyte creates, seeds, and harvests life sciences innovation. Probing the world's top biotech research institutions, LaunchCyte acquires technologies that satisfy today's most compelling heal...
4.Welcome to LaunchCyte   (91%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT WELCOME TO THE HOME OF BIOTECH VENTURE CREATION LaunchCyte creates, seeds, and harvests life sciences innovation. Probing the world's top biotech research institutions, LaunchCyte acquires technologies that satisfy today's most compelling heal...
5.LaunchCyte management   (79%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT MANAGEMENT Tom Petzinger Partner/CEO In addition to serving as CEO and chairman of LaunchCyte, Tom serves as a director of Reaction Biology Corporation, and Immunetrics Inc. Prior to co-founding LaunchCyte, he spent 22 years at The Wall Street...
6.LaunchCyte Press   (75%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT ARCHIVED PRESS 2003 LaunchCyte: Pittsburgh Life Sciences Greenhouse Strikes Commercialization Partnership with LaunchCyte — May 27, 2003 Immunetrics: Ronald B. Herberman, M.D., Joins Advisory Board as Founding Member of Immunetrics —...
7.LaunchCyte portfolio   (62%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT PORTFOLIO LaunchCyte maps proprietary life science technologies to compelling marketplace needs. Read about our current portfolio companies and watch this space as new ventures emerge from our pipeline Reaction Biology cuts orders of magnitude ...
8.LaunchCyte Press   (62%):
HOME l ABOUT l PORTFOLIO l MANAGEMENT l PRESS l CONTACT PRESS Crystalplex in the news: Following the (nano)dots http://www.post-gazette.com/pg/04033/268249.stm LaunchCyte in the news: Time of struggle may end... http://www.post-gazette.com/pg/04008/259028.stm Read the Spring 2003 cover story from th...
9.Portfolio Detail   (35%):
<a href="/portfolio.jsp?restrictids=coName&restrictvalues= Portfolio Roster A - F G, Portfolio Roster G - L M, Portfolio Roster M - R S" class="two">Portfolio Roster S - Z Reaction Biology Corp. Reaction Biology (formerly Morewood Molecular) has a unique technology that is helping to detect pr...

Page: 1  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others